13D/13G Filings - Sofinnova Capital VIII

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
4:29 pm
Purchase
2024-12-31 13G Quince Therapeutics, Inc.
QNCX
Sofinnova Capital VIII 2,397,711
5.400%
242,017increase
(+11.23%)
Filing
History
2024-08-06
8:04 pm
Sale
2024-05-01 13G Quince Therapeutics, Inc.
QNCX
Sofinnova Capital VIII 2,155,694
4.990%
-22,456decrease
(-1.03%)
Filing
History
2024-02-12
09:00 am
Purchase
2023-12-31 13G Quince Therapeutics, Inc.
QNCX
Sofinnova Capital VIII 2,178,150
5.100%
2,178,150increase
(New Position)
Filing
History